Kaletra Tablets Offer Convenience Benefits, Abbott Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The firm plans to transition all patients on Kaletra (lopinavir/ritonavir) capsules to the new tablet formulation, which reduces the pill count and eliminates the need for refrigeration.